G01N 33/56994
Herpetoviridae
Official title: {Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus}
G01N33/56994 (Herpetoviridae) appears on 151 US grants and 209 published applications in this corpus.
Search patents in G01N- Granted patents
- 151
- Published applications
- 209
- Assignees
- 173
- Inventors
- 546
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 6 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 7 | 0 |
| 2001 | 5 | 4 |
| 2002 | 0 | 4 |
| 2003 | 3 | 6 |
| 2004 | 2 | 6 |
| 2005 | 7 | 6 |
| 2006 | 3 | 9 |
| 2007 | 3 | 6 |
| 2008 | 3 | 8 |
| 2009 | 4 | 4 |
| 2010 | 2 | 5 |
| 2011 | 3 | 10 |
| 2012 | 3 | 8 |
| 2013 | 4 | 6 |
| 2014 | 5 | 9 |
| 2015 | 6 | 16 |
| 2016 | 9 | 12 |
| 2017 | 5 | 9 |
| 2018 | 8 | 11 |
| 2019 | 10 | 8 |
| 2020 | 4 | 7 |
| 2021 | 2 | 9 |
| 2022 | 3 | 6 |
| 2023 | 6 | 19 |
| 2024 | 4 | 8 |
| 2025 | 6 | 8 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibody to Epstein Barr virus and uses thereof2 Jun 2026US 12,643,939 B2The Council of the Queensland Institute of Medical Research
- Antibodies for detecting Epstein Barr virus-positive gastric cancer5 May 2026US 12,618,839 B2Arizona Board of Regents on behalf of Arizona State University
- T cell antigen receptor, multimeric complex thereof, and preparation method therefor and use thereof24 Mar 2026US 12,583,910 B2Bristar Immunotech Limited
- Diagnosis of congenital cytomegalovirus infection23 Dec 2025US 12,504,429 B2Hadasit Medical Research Services and Development Ltd.
- Anti-varicella-zoster virus antibody9 Dec 2025US 12,491,386 B2Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Diagnosis of congenital cytomegalovirus infection18 Jun 2026US 2026/0168998 A1Hadasit Medical Research Services and Development Ltd.
- Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely26 Mar 2026US 2026/0086092 A1
- Detection of anti-viral cdr3s in cancer5 Feb 2026US 2026/0036592 A1University of South Florida
Most cited
By later US patents
- Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus80US 6,013,433 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 2000
- Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus78US 6,126,944 AThe United States of America as represented by the Department of Health and Human Services · 2000
- Multiplex flow assays preferably with magnetic particles as solid phase70US 6,280,618 B1Bio-Rad Laboratories, Inc. · 2001
- Immunoassay diagnostic kit63US 5,620,845 AAmpcor, Inc. · 1997
- Specific binding agents for KSHV vIL-6 that neutralize a biological activity62US 7,108,981 B2The United States of America as represented by the Department of Health and Human Services · 2006